0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-11-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11647227 2023-11-01 2025-03-31 11647227 2025-03-31 11647227 2023-10-31 11647227 2022-11-01 2023-10-31 11647227 2023-10-31 11647227 2022-10-31 11647227 bus:OrdinaryShareClass1 2023-11-01 2025-03-31 11647227 bus:OrdinaryShareClass2 2023-11-01 2025-03-31 11647227 bus:Director1 2023-11-01 2025-03-31 11647227 core:WithinOneYear 2025-03-31 11647227 core:WithinOneYear 2023-10-31 11647227 core:ShareCapital 2025-03-31 11647227 core:ShareCapital 2023-10-31 11647227 core:RetainedEarningsAccumulatedLosses 2025-03-31 11647227 core:RetainedEarningsAccumulatedLosses 2023-10-31 11647227 bus:Director1 2023-10-31 11647227 bus:Director1 2025-03-31 11647227 bus:Director1 2022-10-31 11647227 bus:Director1 2023-10-31 11647227 bus:Director1 2022-11-01 2023-10-31 11647227 bus:SmallEntities 2023-11-01 2025-03-31 11647227 bus:AuditExemptWithAccountantsReport 2023-11-01 2025-03-31 11647227 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2025-03-31 11647227 bus:PrivateLimitedCompanyLtd 2023-11-01 2025-03-31 11647227 bus:FullAccounts 2023-11-01 2025-03-31 11647227 bus:OrdinaryShareClass1 2025-03-31 11647227 bus:OrdinaryShareClass1 2023-10-31 11647227 bus:OrdinaryShareClass2 2025-03-31 11647227 bus:OrdinaryShareClass2 2023-10-31 11647227 bus:AllOrdinaryShares 2025-03-31 11647227 bus:AllOrdinaryShares 2023-10-31
COMPANY REGISTRATION NUMBER: 11647227
SPD Health Estates Ltd
Filleted Unaudited Financial Statements
31 March 2025
SPD Health Estates Ltd
Statement of Financial Position
31 March 2025
31 Mar 25
31 Oct 23
Note
£
£
Current assets
Debtors
4
1,140
103
Cash at bank and in hand
174
224
-------
----
1,314
327
Creditors: amounts falling due within one year
5
1,267
644
-------
----
Net current assets/(liabilities)
47
( 317)
----
----
Total assets less current liabilities
47
( 317)
----
----
Net assets/(liabilities)
47
( 317)
----
----
Capital and reserves
Called up share capital
6
100
100
Profit and loss account
( 53)
( 417)
----
----
Shareholders funds/(deficit)
47
( 317)
----
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 4 April 2025 , and are signed on behalf of the board by:
Mr S P Deveney
Director
Company registration number: 11647227
SPD Health Estates Ltd
Notes to the Financial Statements
Period from 1 November 2023 to 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Sycamore House, Sutton Quays Business Park, Sutton Weaver, Runcorn, Cheshire, WA7 3EH.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances .
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method .
Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
4. Debtors
31 Mar 25
31 Oct 23
£
£
Corporation tax repayable
103
Other debtors
1,140
-------
----
1,140
103
-------
----
5. Creditors: amounts falling due within one year
31 Mar 25
31 Oct 23
£
£
Accruals and deferred income
408
360
Corporation tax
859
Director loan accounts
284
-------
----
1,267
644
-------
----
6. Called up share capital
Issued, called up and fully paid
31 Mar 25
31 Oct 23
No.
£
No.
£
Ordinary shares of £ 1 each
95
95
95
95
Ordinary Class A shares of £ 1 each
5
5
5
5
----
----
----
----
100
100
100
100
----
----
----
----
7. Director's advances, credits and guarantees
During the period the director entered into the following advances and credits with the company:
31 Mar 25
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr S P Deveney
( 284)
( 12,234)
13,658
1,140
----
--------
--------
-------
31 Oct 23
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr S P Deveney
740
( 2,372)
1,348
( 284)
----
-------
-------
----